Last year, Enzon Pharmaceuticals terminated its co-development agreement with Inex after the FDA issued a "non-approvable" letter for Marqibo, saying Phase III trials were necessary.
Alcatel-Lucent and China Mobile signed a co-creation agreement in January 2012 to conduct joint development and test activities on a series of lightRadio TD-LTE projects to speed the deployment of LTE in China.